(Karlsruhe-GER, 26 June 2020)
Karlsruhe (GER) – joimax^®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, is pleased to announce a new countrywide distributor in Taiwan, Hi-Clearance Inc. With the aim of building an effective, long-term relationship, the strategic supplier partnership is a further milestone in the international growth of joimax^® .

“Hi-Clearance is our ideal sales and service partner,” says joimax^® CEO and Founder Mr. Wolfgang Ries. With their streamlined structure and process in place, we are confident joimax^® will penetrate this new market very successfully”.

Hi-Clearance Inc. has over 239 employees, and is a well-known supplier of medical materials and equipment in Taiwan. “We are very pleased about the new strategic partnership and are excited to continue the strong growth of both companies,” states Hi-Clearance Chairman Mr. John Lee and President Mr. Ernie Chen. “We are dedicated to establishing joimax^® as the leading brand of endoscopic spine surgery in Taiwan.”

Hi-Clearance Inc. is headquartered in Taipei with four other branches spread across the country. The main business includes products for Hemodialysis, Critical Care, Dental, Cardiology, Homecare Devices, Nutrition and a major Spine Surgery Division. In 2019, sales were USD 107 million.

KARLSRUHE, Germany–(BUSINESS WIRE)–joimax®, the German-based market leader in technologies and training methods for full-endoscopic and minimally invasive spinal surgery, presented at the ESPINEA® World Summit at the prestigious Royal College of Surgeons of Edinburgh, PASMISS in Taiwan, NASSi in Bangkok, the ASEAN MISST in Jakarta, and at the first Annual Endoscopic Spine Surgery Symposium at the Seattle Science Foundation.

 

 

From July 13 to 15 more than 80 attendees from 22 countries connected at the ESPINEA® World Summit. “This historic event was a major milestone in the educational training activity of ESPINEA^®, where we are proud to guide highly active surgeons from around the world within this encouraging field of endoscopic spinal therapy,” concluded ESPINEA^® board members Dr. Alastair Gibson and Dr. Menno Iprenburg.

The July events provided joimax^® the ideal opportunity to launch the highly anticipated surgical access systems, iLESSYS^® Biportal and TESSYS^® Trans SAP, along with the new electrosurgical probe, Vaporace^® Bipo, which are key to the soon-to-be announced endoscopic expandable fusion platform.

joimax^® will also share its latest developments at EUROSPINE in Frankfurt, affording participants an opportunity to attend an open house at their global headquarters in Karlsruhe, where they will further learn about joimax^®’s research and manufacturing capabilities. Moreover, the joimax^® US team will welcome NASS attendees in its hometown of Los Angeles.

“We are excited to see the widespread acceptance of endoscopic spine surgery around the globe,” said joimax^® Founder and CEO Wolfgang Ries. “Having reached a tipping point, the NASS endoscopic “Surgical Stadium” event, will be another highlight the spine community can look forward to”. For further information and event registration, contact joimax^®.

 

KARLSRUHE, Germany – (BUSINESS WIRE) – The newly renovated and expanded Endoscopic Spinal Academy (ESPINEA®) facilities, sponsored by joimax®, makes exceptionally, high-quality training accessible in an innovative and appealing environment. Every day, the Academy offers educational and hands-on workshops to surgery teams, customers and partners.

Ries took on the newly created role of Executive Vice President, Business Development and Operations at joimax®. In this position, based in Germany, he will be responsible for scaling global operations to ensure joimax® continues its exponential growth. Formerly the General Manager, for the past six of his 13-year tenure with joimax®, Ries built out the United States and Latin American markets. 

“We are continuously developing and adapting our programs to meet customer demand”.

Courses and workshops at a pre-clinical and clinical levels

For almost five years, ESPINEA®, which is accredited by the Royal College of Surgeons of Edinburgh, has stood for excellence in training in the field of endoscopic spinal surgery. After the recent inauguration of ESPINEA® China, joimax® has refurbished and enlarged the existing Karlsruhe training facilities into a modern, state-of-the art center to support their growing educational and training programs. The showroom demonstrates solutions from joimax®, the market leader in endoscopic spinal surgery technologies, enabling visitors to experience this mastery daily.

Organized in sections, by product line, practitioners can try out each clinical model, simulating an operative environment, and learn firsthand about the positive ergonomics and streamlined workflow of these offerings. All labs are equipped with integrated joimax® surgery systems, including the latest generation endoscopic tower, NAVENTO®. The surgery stations are digitally connected to imaging and to the joimax® Intracs® electromagnetic navigation system so that the endoscopic spinal surgery methods and applications can be reproduced during training. Moreover, the furnishings have been fully optimized so that the rooms can be easily adapted to new products and solutions.

“As a leading innovator in spinal surgery techniques, it’s important that ESPINEA® offers a pioneering center to further education and training,” said Wolfgang Ries, CEO and founder of joimax® and chairman and founder of ESPINEA®. “The dynamic, holistic and needs-oriented program sets new standards.”

The main focus is on endoscopic spinal care solutions for pain therapy, decompression, deherniation, and spinal stabilization. All hands-on sections have an open lab design, and bring the concept to life on how the products work together.

Setting standards in training of endoscopic spinal surgery

Professional knowledge and well-practiced skills are the building blocks for successful endoscopic spinal surgery.

“We are continuously developing and adapting our programs to meet customer demand,” said Susanne Schmidinger, senior director, global marketing and education. “We are convinced that our holistic and target-oriented education puts surgery teams in the position to optimally implement our available technologies and solutions for their patients.“

At the facility, an experienced, dedicated global team of certified faculty share their expertise and know-how. Every trainee is individually accompanied along the entire learning journey.

“It’s important that surgeons be able to directly and efficiently apply joimax® systems and methods in their daily work,” said Ries. “That’s why we developed the ESPINEA® 3-step education program of visitation, hands-on workshop, and simulated live surgery.”

The program is available at ESPINEA® USA, Asia, China, and Europe.

 

Karlsruhe, GER– July 15, 2019 –joimax^®, the Germany-based market leader of technologies and training methods for full-endoscopic minimally-invasive spinal surgery, announces the official sales launch of its complete EndoLIF^® family. EndoLIF^® is an instrument set for endoscopic-assisted minimally invasive lumbar interbody fusion. As already announced and showcased at earlier events, the EndoLIF^® product line consists of three members now: the well-known EndoLIF^® O/On-Cage, the EndoLIF^® Delta Cage, and the latest EndoLIF^® Double Wedge Cage. The complete EndoLIF^® product family is now CE-approved and fully available. Moreover, the EndoLIF^® O/On-Cage is FDA-approved.

All EndoLIF^® Implants are manufactured using a 3D printing process, which ensures an open diamond cell structure. The cages are safely implanted via the guide wire and are fillable with bone or bone substitute material. With their rough and porous surface, the implants guarantee optimal bone ingrowth, stability and finally fusion.

The EndoLIF^® Cage family provides the right implant for every patient and is the perfect solution for endoscopic spinal fusion. With the gentle and atraumatic access via gradual tissue dilatation, muscles remain intact leaving important biomechanical structures in place after surgery.

Like with any endoscopic procedure compared to open surgery, all advantages for fusion are now given with the EndoLIF^® program also. With one EndoLIF^® Instrument Set all three cages of the EndoLIF^® family can be implemented.

Dr. Florian Zentz, (Munich, GER) emphasizes “the extraordinarily high primary stability of the EndoLIF^® DoubleWedge-Cage”. He continues enthusiastically: “After insertion the cage sits very firmly in the intervertebral disc space and adjusts the angulation up to 18 degrees, almost directly enabling an optimal lordosis correction.”

Dr. Ralf Wagner, (Frankfurt, GER) is also convinced of the obvious advantages: “The Delta Cage is ideal for the posterior lumbar interbody fusion (PLIF) offering a gentle posterior alternative, especially at level L5-S1 with its large interlaminar window.

Maximilian Ries

Ries took on the newly created role of Executive Vice President, Business Development and Operations at joimax^®. In this position, based in Germany, he will be responsible for scaling global operations to ensure joimax^® continues its exponential growth. Formerly the General Manager, for the past six of his 13-year tenure with joimax^®, Ries built out the United States and Latin American markets.

Tony Troncale

Troncale was promoted to General Manager; he was formerly Vice President of Marketing and Business Development at joimax^® Inc. Over the past two years, Troncale, in addition to increasing his responsibilities, successfully capitalized on the significant interest in endoscopic techniques to expand US sales operations. He joined joimax^® in 2021 bringing 20-years of experience in the spinal device industry where he served in sales and marketing leadership roles at Stryker, K2M, and Synthes Spine. Contributing to the global organization’s continuous strong sales growth was the launch of a new surgical access system, “Tessys^® Trans SAP” and the global expansion of the ESPINEA^® Education Academy.

Wolfgang Ries

“I am extremely pleased with our 2022 global performance and the significant interest in endoscopic spine surgery,” stated joimax^® Founder and CEO Wolfgang Ries. “With Max and Tony in their new roles, our market-leading endoscopic spine technologies, and our anticipated launch of two more new surgical access systems later in 2023, we are well positioned for another very successful year.”

IRVINE, CA – May 13, 2019 – joimax^®,, the Germany-based market leader of technologies and training methods for full-endoscopic, minimally-invasive spinal surgery, is showcasing its Integrated Navigation Tracking & Control System, Intracs^®em, at this year’s Global Spine Congress (GSC), which is currently being held in Toronto, Canada. The company is also promoting the system at the annual meeting of the German Society of Neurosurgery (DGNC), being held concurrently in Wurzburg, Germany.

The Intracs^®em electromagnetic navigation system is simple to set up, very user-friendly, and seamlessly integrates into the joimax^® endoscopic tower. It allows for navigation during any endoscopic procedure performed with the joimax^® endoscopic surgical systems, TESSYS^® (transforaminal) and iLESSYS^® (interlaminar). Beyond that, it can serve as a stand-alone device.

The system relies on electromagnetic tracking, affording simultaneous navigation of multiple instruments such as needles, guiding rods, reamers and endoscopes. It was developed by joimax^®  for easy planning of endoscopic approaches to the spine, as well as other minimally invasive procedures, like percutaneous fusions.

Various Intracs^®em sensors guarantee the highest accuracy. Plus, for the patients’ benefit, the procedure can be carried out without further X-ray control – only starting X-rays are required. As a result, access, intervention time, and radiation exposure, are reduced to a minimum.

The system is CE-Marked. Currently, clinical trials and applications are running in Europe and Asia, where the product has already launched. In specific Asian countries, like Taiwan, the first systems have been sold and shipped.

Users are very impressed with the usability of the system. “I didn’t expect that navigation for both transforaminal and interlaminar procedures can be made so easy and that the set-up time can be so much streamlined,“ states Prof. Michael Kraus, spine specialist in Augsburg, Germany.  “And for the thoracic approach, it is so precise and a tremendous help,” continues Dr. Erik Traupe, spine specialist in Munich, Germany.

The launch of Intracs^®em is a key milestone for joimax^®. As part of its global strategy, joimax^®  is providing surgeons, worldwide, with the devices they need for safe, easy and gentle spinal therapies, with US-FDA submission planned for Q2, 2019. “We are committed to overcoming any obstacles and concerns related to minimally invasive, endoscopic spine surgery,” states joimax^® CEO and Founder Wolfgang Ries. “Our success lies with our innovative, user-friendly devices and instruments, and our ability to provide both doctor and patient with outstanding safety built into our systems.” Moreover, a well established and targeted clinical training program for the spinal surgical community, named CM3, rounds out the joimax^® educational offering. Earlier this year, joimax^® launched ESPINEA^®, an Endoscopic Spine Academy focused on a complete endoscopic spine curriculum. Designed as a full training program to elevate surgeons to the next level of expertise, ESPINEA^® offers professional and high-quality education for endoscopic spine treatment specialists, worldwide. The ESPINEA^® Training and Education Centers are located in Karlsruhe, Germany in the newly opened joimax^® building, and in Irvine, CA, where joimax^® opened new labs and training rooms last November.